Last updated: November 3, 2020
Sponsor: China Medical University Hospital
Overall Status: Active - Recruiting
Phase
N/A
Condition
Sleep Apnea Syndromes
Allergy
Nasal Obstruction
Treatment
N/AClinical Study ID
NCT04621513
CMUH109-REC1-089
Ages 6-18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Age less than 18 years old
- Patients with persistent, moderate to severe allergic rhinitis who have been diagnosedby ARIA (2014) diagnostic criteria
- AHI by polysomnography is >1 and diagnosis with obstructive sleep apnea.
Exclusion
Exclusion Criteria:
- Abnormal craniofacial structure and require surgery.
- Patients with sleep apnea caused by muscular dysplasia of the upper respiratory tract ( eg. cerebral palsy, Down syndrome, and other congenital muscular hypoplasia).
- Mental or behavioral abnormalities that cannot cooperate with the researcher, such asschizophrenia, depression, suicidal ideation, etc.
- Allergy to the treatment previously
- Any disease or organ system dysfunction that may be life-threatening
Study Design
Total Participants: 60
Study Start date:
July 29, 2020
Estimated Completion Date:
December 31, 2022
Study Description
Connect with a study center
China Medical University & Hospital
Taichung, 40447
TaiwanActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.